New Rhinitis Treatment
The news is “Paediatric Allegra,” the new option for treating rhinitis, is an antihistamine with raspberry flavor, which is characterized by not cause sedation, having a rapid onset of action and an anti-inflammatory effect. “It is effective, well tolerated and has a high level of security,” he said.
Their presentation is an oral suspension, easily dosed with a syringe metering according to patient age and severity of the disease. It is a prescription medicine, so parents should consult your pediatrician, he said.
Allegra Oral Suspension Paediatric, part of the portfolio of laboratory products for children known as Sanofi Aventis Pediatrics, said Dr. Rossana Juarez, medical director of Sanofi Aventis for Central America and the Caribbean.
Sanofi Aventis is a research and development company where we study many molecules such as Allegra, “we have many products for pediatricians, but until now we are combining to complete our portfolio of pediatrics and hope to continue expanding in the future,” he said.
Allegra is noted that drug known by physicians in their presentation for adults, and was therefore eagerly awaited pediatric presentation for its high efficacy and safety profile.